Form 8-K - Current report:
SEC Accession No. 0001193125-26-071516
Filing Date
2026-02-25
Accepted
2026-02-25 16:05:29
Documents
12
Period of Report
2026-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20260225.htm   iXBRL 8-K 47943
2 EX-99.1 rxst-ex99_1.htm EX-99.1 405094
3 GRAPHIC img261313502_0.jpg GRAPHIC 2587
  Complete submission text file 0001193125-26-071516.txt   578131

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rxst-20260225.xsd EX-101.SCH 23863
14 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20260225_htm.xml XML 4511
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 26678470
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)